Brief: Iterum Therapeutics Reports First Quarter 2022 Financial Results
13/05/2022 12:34
May 13 (Reuters) - Iterum Therapeutics PLC ITRM.O :
* ITERUM THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
* ITERUM THERAPEUTICS PLC - QTRLY NET LOSS PER SHARE $0.02
* ITERUM THERAPEUTICS PLC - QTRLY NON-GAAP NET LOSS PER
SHARE
$0.03
* ITERUM THERAPEUTICS - BASED ON CURRENT OPERATING PLAN,
EXPECTS
CURRENT CASH, SHORT-TERM INVESTMENTS WILL BE SUFFICIENT TO FUND
OPERATIONS INTO 2024
Source text for Eikon: ID:nGNXbJHQxV
Further company coverage: ITRM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity